Scientists are exploring the extraordinary longevity of queen bees, which live up to 20 times longer than worker bees, to uncover potential life-extending benefits for humans. The UK’s Advanced Research and Invention Agency (ARIA) is investigating the role of a specific peptide in royal jelly, the substance that sustains queen bees. Early experiments show that injecting this peptide into worker bees significantly increased their lifespan, while human trials suggest additional effects such as enhanced physical growth and improved reproductive health.

Research highlights the unique composition of royal jelly, which is lower in sugar and rich in vitamins, nutrients, and fatty acids compared to honey or bee pollen. Studies indicate that queen bees may achieve extended lifespans by reducing oxidative damage through antioxidant mechanisms and regulating insulin signaling. However, harvesting royal jelly remains a labor-intensive process, requiring meticulous manual collection from hive larvae.

A new product, the Aeon patch, claims to replicate the peptide’s effects by stimulating the body’s natural production of the compound. Proponents argue that the patch offers a cost-effective alternative to consuming large quantities of royal jelly, which would require thousands of dollars worth of extract. The patch is marketed alongside other wellness products, with claims of enhancing stem cell activity and targeting inflammation.

Regulatory warnings emphasize that the product is not intended to diagnose or treat medical conditions. While the research into queen bee biology continues, the ethical implications of royal jelly harvesting remain a topic of debate among beekeepers and consumers.